tradingkey.logo

Senestech Inc

SNES

2.390USD

+0.169+7.66%
Close 05/02, 16:00ETQuotes delayed by 15 min
2.48MMarket Cap
LossP/E TTM

Senestech Inc

2.390

+0.169+7.66%
More Details of Senestech Inc Company
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Company Info
Company codeSNES
Company nameSenestech Inc
IPO dateDec 08, 2016
Founded at2015
CEOMr. Joel L. Fruendt
Number of employees23
Security typeOrdinary Share
Fiscal year-endDec 08
Address777 W. Pinnacle Peak Road
CityPHOENIX
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code85027
Phone19287794143
Websitehttps://senestech.com/
Company codeSNES
IPO dateDec 08, 2016
Founded at2015
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Matthew K. (Matt) Szot, CPA
Mr. Matthew K. (Matt) Szot, CPA
Independent Director
Independent Director
2.00
--
Mr. Thomas C. (Tom) Chesterman
Mr. Thomas C. (Tom) Chesterman
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
--
--
Mr. Phil N. Grandinetti, III
Mr. Phil N. Grandinetti, III
Independent Director
Independent Director
--
--
Mr. Jake S. Leach
Mr. Jake S. Leach
Independent Director
Independent Director
--
--
Mr. Joshua M. Moss
Mr. Joshua M. Moss
Independent Director
Independent Director
--
--
Dr. Jamie Bechtel, J.D., Ph.D.
Dr. Jamie Bechtel, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joel L. Fruendt
Mr. Joel L. Fruendt
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Matthew K. (Matt) Szot, CPA
Mr. Matthew K. (Matt) Szot, CPA
Independent Director
Independent Director
2.00
--
Mr. Thomas C. (Tom) Chesterman
Mr. Thomas C. (Tom) Chesterman
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Executive Vice President, Treasurer, Secretary
--
--
Mr. Phil N. Grandinetti, III
Mr. Phil N. Grandinetti, III
Independent Director
Independent Director
--
--
Mr. Jake S. Leach
Mr. Jake S. Leach
Independent Director
Independent Director
--
--
Mr. Joshua M. Moss
Mr. Joshua M. Moss
Independent Director
Independent Director
--
--
Dr. Jamie Bechtel, J.D., Ph.D.
Dr. Jamie Bechtel, J.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Revenue Breakdown
Currency: USDUpdate time: Wed, Mar 5
Currency: USDUpdate time: Wed, Mar 5
FY2024Q2
No Data
By RegionUSD
Name
Revenue
Proportion
United States
459.00K
0.00%
International
0.00
0.00%
By Business
By Region
No Data
Shareholder
Update time: 17 hours ago
Update time: 17 hours ago
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
The Lind Partners, LLC
6.31%
PFS Cap MGT Co
3.41%
Geode Capital Management, L.L.C.
0.50%
UBS Financial Services, Inc.
0.23%
Tower Research Capital LLC
0.07%
Other
89.49%
Shareholder Statistics
Shareholder
Proportion
The Lind Partners, LLC
6.31%
PFS Cap MGT Co
3.41%
Geode Capital Management, L.L.C.
0.50%
UBS Financial Services, Inc.
0.23%
Tower Research Capital LLC
0.07%
Other
89.49%
Type
Shareholder
Proportion
Investment Advisor
6.54%
Corporation
3.41%
Investment Advisor/Hedge Fund
0.50%
Hedge Fund
0.07%
Individual Investor
0.01%
Other
89.48%
Institutional Shareholding
Update time: Tue, Mar 4
Update time: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
30
178.04K
10.03%
+80.37K
2024Q4
32
178.31K
17.25%
+80.51K
2024Q3
38
76.44K
15.87%
+51.77K
2024Q2
37
16.40K
4.22%
-8.22K
2024Q1
40
19.23K
5.47%
+9.13K
2023Q4
37
6.33K
7.03%
+618.00
2023Q3
35
1.33K
4.01%
+245.00
2023Q2
37
641.00
1.55%
-864.00
2023Q1
42
293.00
5.66%
-1.34K
2022Q4
44
944.00
18.55%
-48.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Lind Partners, LLC
112.00K
6.41%
+94.64K
+545.35%
Dec 31, 2024
PFS Cap MGT Co
60.51K
3.46%
+59.27K
+4.78K%
Dec 31, 2024
UBS Financial Services, Inc.
4.07K
0.23%
+4.07K
--
Dec 31, 2024
Tower Research Capital LLC
1.29K
0.07%
-458.00
-26.26%
Dec 31, 2024
Fruendt (Joel Lee)
110.00
0.01%
--
--
May 24, 2024
Leach (Jacob Steven)
62.00
0%
--
--
May 24, 2024
BofA Global Research (US)
8.00
0%
+4.00
+100.00%
Dec 31, 2024
Szot (Matthew K)
2.00
0%
--
--
May 24, 2024
Chiavarini (Delphine Francois)
1.00
0%
--
--
May 24, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jul 23, 2024
Merger
10<1
Jul 23, 2024
Merger
10<1
Jul 23, 2024
Merger
10<1
Jul 23, 2024
Merger
10<1
Nov 15, 2023
Merger
12<1
Nov 15, 2023
Merger
12<1
Date
Type
Ratio
Jul 23, 2024
Merger
10<1
Jul 23, 2024
Merger
10<1
Jul 23, 2024
Merger
10<1
Jul 23, 2024
Merger
10<1
Nov 15, 2023
Merger
12<1
Nov 15, 2023
Merger
12<1
Nov 15, 2023
Merger
12<1
Nov 15, 2023
Merger
12<1
Nov 15, 2022
Merger
20<1
Nov 15, 2022
Merger
20<1
View more